Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155008 · ClinicalTrials.gov registry record · Phase 4
Nutrition and Pharmacological Algorithm for Oncology Patients Study
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT04155008: Clinical Trial Phase 4 study, sponsored by Montefiore Medical Center.
NCT04155008 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04155008, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.
Primary Outcome
The primary outcome of this study is assessing the impact on quality of life for the oncology patients by using an algorithm for nutrition intervention and appetite stimulants through utilizing Functional Assessment of Cancer Therapy-General Population (FACT-GP).
Interventions
- DRUG Dexamethasone
- DRUG Dronabinol
- BEHAVIORAL Nutrition Intervention
- DRUG Mirtazapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2021-04-05 |
| Phase | Phase 4 |
Why NCT04155008 stopped before completion
NCT04155008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Dexamethasone is the first listed.
NCT04155008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04155008 about?
NCT04155008 is a clinical study titled "Nutrition and Pharmacological Algorithm for Oncology Patients Study". Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatme...
What is the current status of trial NCT04155008?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2021-03-01. Estimated completion is 2021-04-05.
What interventions are being tested in trial NCT04155008?
The interventions under investigation include: Dexamethasone (DRUG), Dronabinol (DRUG), Nutrition Intervention (BEHAVIORAL), Mirtazapine (DRUG).
Who is sponsoring clinical trial NCT04155008?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04155008's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI